Development progress in 2018 for acute ischemic stroke drugs will fuel market growth, says GlobalData
Activase (alteplase) is currently the only FDA-approved drug available for the treatment of acute ischemic stroke (AIS) in the 8MM*; however, novel drugs designed to...